LPL Financial LLC Raises Position in DaVita Inc. $DVA

Key Points

• LPL Financial LLC increased its stake in DaVita Inc. by 36.2% during the 1st quarter, now owning 18,689 shares valued at approximately $2.86 million.
• Analyst ratings have varied, with Barclays lowering the target price from $169.00 to $160.00, while Wall Street Zen upgraded DaVita to a "buy" rating.
• In its latest quarterly earnings, DaVita reported $2.95 EPS, surpassing analyst estimates and a 6.1% year-over-year revenue increase.

LPL Financial LLC raised its holdings in shares of DaVita Inc. (NYSE:DVA - Free Report) by 36.2% in the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 18,689 shares of the company's stock after purchasing an additional 4,968 shares during the period. LPL Financial LLC's holdings in DaVita were worth $2,859,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also made changes to their positions in the company. UMB Bank n.a. increased its stake in shares of DaVita by 65.5% during the first quarter. UMB Bank n.a. now owns 192 shares of the company's stock valued at $29,000 after purchasing an additional 76 shares in the last quarter. Copia Wealth Management bought a new position in shares of DaVita during the fourth quarter valued at approximately $30,000. Coppell Advisory Solutions LLC increased its stake in shares of DaVita by 50.0% during the fourth quarter. Coppell Advisory Solutions LLC now owns 300 shares of the company's stock valued at $45,000 after purchasing an additional 100 shares in the last quarter. GeoWealth Management LLC increased its stake in shares of DaVita by 30.6% during the fourth quarter. GeoWealth Management LLC now owns 525 shares of the company's stock valued at $79,000 after purchasing an additional 123 shares in the last quarter. Finally, Blue Trust Inc. increased its stake in shares of DaVita by 150.9% during the first quarter. Blue Trust Inc. now owns 567 shares of the company's stock valued at $87,000 after purchasing an additional 341 shares in the last quarter. Institutional investors own 90.12% of the company's stock.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on DVA shares. Truist Financial set a $148.00 price target on shares of DaVita in a research report on Friday, August 8th. Wall Street Zen raised shares of DaVita from a "hold" rating to a "buy" rating in a research report on Friday, April 25th. Finally, Barclays reduced their price target on shares of DaVita from $169.00 to $160.00 and set an "equal weight" rating for the company in a research report on Thursday, August 7th. Three analysts have rated the stock with a Hold rating, According to MarketBeat, the company presently has a consensus rating of "Hold" and an average target price of $164.00.

Insider Buying and Selling

In other DaVita news, insider James O. Hearty sold 2,351 shares of DaVita stock in a transaction that occurred on Wednesday, July 23rd. The shares were sold at an average price of $150.00, for a total value of $352,650.00. Following the completion of the sale, the insider owned 26,038 shares of the company's stock, valued at approximately $3,905,700. The trade was a 8.28% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 1.50% of the company's stock.

DaVita Stock Performance

NYSE:DVA traded up $2.49 during trading hours on Friday, reaching $140.07. The company had a trading volume of 71,405 shares, compared to its average volume of 856,671. The company has a current ratio of 1.39, a quick ratio of 1.34 and a debt-to-equity ratio of 23.18. DaVita Inc. has a 52 week low of $126.07 and a 52 week high of $179.60. The firm has a market cap of $10.02 billion, a price-to-earnings ratio of 13.78, a PEG ratio of 0.98 and a beta of 1.09. The firm's 50 day moving average price is $139.55 and its 200-day moving average price is $144.38.

DaVita (NYSE:DVA - Get Free Report) last posted its earnings results on Tuesday, August 5th. The company reported $2.95 EPS for the quarter, topping analysts' consensus estimates of $2.70 by $0.25. DaVita had a net margin of 6.35% and a return on equity of 369.39%. The business had revenue of $3.38 billion during the quarter, compared to the consensus estimate of $3.36 billion. During the same quarter in the previous year, the firm posted $2.00 EPS. The firm's revenue was up 6.1% on a year-over-year basis. DaVita has set its FY 2025 guidance at 10.200-11.300 EPS. On average, analysts forecast that DaVita Inc. will post 10.76 EPS for the current year.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.